New guidelines for skin lymphoma

British Association of Dermatologists publishes new guidelines for the management of primary cutaneous lymphomas

British Association of Dermatologists logo

The British Association of Dermatologists has published new guidelines on the management of primary cutaneous (skin) lymphomas.

The guidelines provide up-to-date recommendations on the treatment of skin lymphomas in the UK. They cover:

As well as traditional treatments for skin lymphomas, the guidelines include targeted therapies and potential future developments.

The United Kingdom Cutaneous Lymphoma Group (UKCLG) in collaboration with the British Association of Dermatologists has recently updated it’s guidelines for the management of cutaneous lymphomas. The UKCLG is the only UK multi-professional organisation dedicated to treating patients with cutaneous lymphoma and comprises of dermatologists, clinical oncologists, haematologists, pathologists and clinical nurse specialists. The new guidelines provide an up-to-date review of the medical literature and evidence-based recommendations for investigation, staging and treatment of patients. They cover both cutaneous T and B-cell lymphomas including rarer sub-types. A major benefit of the new guideline (compared to the original 2003 version) is the provision of charts detailing first, second and third line treatment options for different stages of mycosis fungoides and Sezary syndrome which will be of practical use to clinicians working in the clinic.
Dr Eileen Parry, The United Kingdom Cutaneous Lymphoma Group Secretary

Read more about skin lymphomas or search for clinical trials suitable for people with skin lymphomas.

Are you a clinician interested in skin lymphomas?

Please join us at the UK Cutaneous Lymphoma Group annual meeting on 2 May in Liverpool. This is an opportunity to network, learn from expert speakers and keep up to date with developments. Dermatologists, oncologists, haematologists, nurse specialists, histopathologists, clinician scientists, psychologists and allied members across the multi-disciplinary team are all welcome.